RCUS — Arcus Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSucker Stock

Annual balance sheet for Arcus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	729	499	1,009	759	978
Net Total Accounts Receivable
Net Total Receivables	1.7	747	39	42	25
Prepaid Expenses
Total Current Assets	736	1,262	1,067	831	1,016
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23.6	137	135	143	112
Long Term Investments
Other Long Term Assets
Total Assets	772	1,592	1,345	1,095	1,150
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	122	166	193	184	226
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	270	750	688	633	665
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	502	841	657	462	485
Total Liabilities & Shareholders' Equity	772	1,592	1,345	1,095	1,150
Total Common Shares Outstanding